Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland
Vaccine | 13 Mar 2018
H Rinta-Kokko, AA Palmu, K Auranen, JP Nuorti, M Toropainen, L Siira, MJ Virtanen, H Nohynek and J Jokinen
The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Programme (NVP) in September 2010. The impact of PCV10 vaccination against invasive pneumococcal disease (IPD) in vaccine-eligible children has been high. We evaluated the long-term impact of PCV10 vaccination against IPD in vaccine-eligible and older, unvaccinated children six years after PCV10 introduction with a special focus on cross-protection against PCV10-related serotypes (serotypes in the same serogroups as the PCV10 types).
* Data courtesy of Altmetric.com